Targeted NHP Diagnostics Capitalize on specialized nonhuman primate health screening services and turnkey immunoassay platform to offer bundled solutions for primate colonies, including routine SPF screenings, antibody titer monitoring, and infectious disease testing (tuberculosis, SARS-CoV-2) to research institutions and primate research facilities.

Integrated Platform Value Promote the end-to-end turnkey or OEM immunoassay platform with consumables, detection reagents, analysis software, and reporting to shorten procurement cycles and provide a one-stop solution for labs needing reliable, scalable screening and monitoring.

Growth Readiness Position for expansion through partnerships or pilots with mid-to-large biotech and contract research organizations given current revenue range and modest funding, aiming to scale to larger labs similar to peers in the industry.

Sustainability & Compliance Highlight capabilities around quality control, standardized reporting, and compliance-friendly workflows to attract institutions prioritizing validated assays and audit-ready data across infectious disease screening and vaccine monitoring.

Strategic Partnerships Leverage proximity to major industry players listed as peers by exploring co-development, OEM supply agreements, or distributor relationships to accelerate market penetration in biotech, diagnostics, and research markets.